bibliographicCitation |
Zhu M, Li W, Zhao T, Chen Y, Li T, Wei S, Guo M, Zhai X. Fragment-based modification of 2,4-diarylaminopyrimidine derivatives as ALK and ROS1 dual inhibitors to overcome secondary mutants. Bioorg Med Chem. 2020 Oct 15;28(20):115719. doi: 10.1016/j.bmc.2020.115719. PMID: 33069075. |